Reports

421 Results (Page 2 of 17)

Egypt Markets Research Reports

Pharmaceuticals

Egypt Pharmacovigilance & Drugs Safety Software Market Analysis

Egypt Pharmacovigilance & Drugs Safety Software Market is projected to grow from $xx Mn in 2022 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2022 - 2030. Pharmacovigilance & Drugs Safety Software Market is growing due to the increasing volume and complexity of drug safety data, stringent regulatory requirements and the need for efficient adverse event reporting and management. The market for drug safety solutions and pharmacovigilance is primarily driven by the increasing frequency of adverse drug reactions (ADRs). Additionally, tight government restrictions for drug development before and after commercialization as well as outsourcing firms growing use of pharmacovigilance software all contribute to the market's expansion. Drug safety solutions, pharmacovigilance automation research partnerships and integration of systems of pharmacovigilance software with electronic health records (EHRs), clinical trial management systems and regulatory databases also are all anticipated to have a positive impact on the market. IQVIA, Accenture, Cognizant, Laboratory Corporation of America Holdings, IBM, ArisGlobal, ICON Plc., Capgemini, Oracle, Parexel International Corporation are the key global market players in Pharmacovigilance & Drugs Safety Software Market.

PUBLISHED: Feb, 2024 | FORMAT: PPT | LAST UPDATED: Feb, 2024 | PRICE: $3999

Pharmaceuticals

Egypt Pharmacy Market Analysis

Egypt Pharmacy Market is projected to grow from $xx Mn in 2022 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2022 - 2030. Pharmacy market is growing due to the increasing number of people suffering from diseases, increasing aging population, growing number of prescriptions and technological advancements like electronic health records (EHRs), pharmacy automation systems, medication dispensing technologies, medication therapy management (MTM) platforms and digital health solutions like E- pharmacy which offer advantages including privacy and confidentiality, free shipping, savings, a shorter purchase process, and a variety of deals. Additionally, it is predicted that the increased use of digital technology by the healthcare sector, rising smartphone penetration, and rising numbers of retailers launching online channels would all contribute to the segment's growth. CVS Health, Boots Walgreens, Cigna, Walmart, Kroger, Rite Aid Corp., Lloyd Pharmacy, Well Pharmacy, Humana Pharmacy Solutions and Matsumoto Kiyoshi are the key global market players in pharmacy market.

PUBLISHED: Feb, 2024 | FORMAT: PPT | LAST UPDATED: Feb, 2024 | PRICE: $3999

Pharmaceuticals

Egypt Photorejuvenation Market Analysis

Egypt Photorejuvenation Market is projected to grow from $xx Mn in 2022 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2022 - 2030. Photorejuvenation market is expected to grow because of Increasing personal disposable income, growing number of skin surgeries, increasing consumer awareness about aesthetic procedures, a growing aging population and increasing prevalence of skin problems among people such as Acne, Birthmarks, fine wrinkles, and scars are formed due to the blocking of the tiny holes in the skin, overgrowth of blood vessels, the breakdown of collagen and elastin in the skin and tissue damage due to the body's natural healing process. Hologic Inc. (Cynosure, Inc.) Lumenis Syneron, Medical Ltd., Lynton Lasers Ltd, EL.EN. S.p.A. (Deka Mela S.r.l.), Fotona Cutera Inc., Lutronic Corporation, Beijing Nubway S & T Co., Ltd, LISA Laser Products are the key global market players in photorejuvenation market.

PUBLISHED: Feb, 2024 | FORMAT: PPT | LAST UPDATED: Feb, 2024 | PRICE: $3999

Pharmaceuticals

Egypt Phycocyanin Market Analysis

Egypt Phycocyanin Market is projected to grow from $xx Mn in 2022 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2022 - 2030. Phycocyanin market is growing globally due to the growth and expansion of the food and beverage industry, the food and beverage sector's increasing focus on innovations, consumers' growing awareness of the benefits of consuming foods and beverages high in protein and other nutrients, the accelerating rate of the use of food additives and colorants, and rising personal disposable income.

PUBLISHED: Feb, 2024 | FORMAT: PPT | LAST UPDATED: Feb, 2024 | PRICE: $3999

Pharmaceuticals

Egypt Pigments Market Analysis

Egypt Pigments Market is projected to grow from $xx Mn in 2022 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2022 - 2030. Pigments market is growing globally due to the increasing demand from end use industries like paints and coatings, automotive, plastics, construction, textiles, growing construction and infrastructure development, technological advancements in pigments manufacturing like nanotechnology and availability of products on e-commerce platforms. The Chemours Company, Huntsman Corporation, Tronox Holdings plc, Sun Chemical Corporation, Clariant Corporation, LANXESS Corporation, Kronos Worldwide, Inc., PPG Industries, Inc., Ferro CorporationAmerican Colors, Inc. are the key global market players in pigments market.

PUBLISHED: Feb, 2024 | FORMAT: PPT | LAST UPDATED: Feb, 2024 | PRICE: $3999

Pharmaceuticals

Egypt Plasma Protease C1-inhibitor Market Analysis

Egypt Plasma Protease C1-inhibitor Market is projected to grow from $xx Mn in 2022 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2022 - 2030. The market for Plasma Protease C1-inhibitor is growing due to increasing product approvals, rising research and development, increase in incidence and prevalence of hereditary angioedema (HAE), a rare genetic condition brought on by a C1-inhibitor deficit or malfunction, Increase in diagnosis of HAE, improvements in available medicines, and the launch of novel therapies. Takeda Pharmaceutical Company, CSL Behring, Pharming Group NV, Ionis pharmaceuticals, BioCryst pharmaceuticals and kalvista pharmaceuticals are the key global market players in Plasma Protease C1-inhibitor Market.

PUBLISHED: Feb, 2024 | FORMAT: PPT | LAST UPDATED: Feb, 2024 | PRICE: $3999

Pharmaceuticals

Egypt Pneumococcal Vaccines Market Analysis

Egypt Pneumococcal Vaccines Market is projected to grow from $xx Mn in 2022 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2022 - 2030. Pneumococcal Vaccines Market is growing due to the increase in the number of people suffering from pneumonia across the globe, rise in demand for specific medication for treating complications associated with the disease such as breathing issues, surge in the financial support to the researchers for developing novel intervention, increase in the introduction of novel pneumococcal vaccines, growing government spending and health-awareness efforts to successfully treat disorder development in technology, surge in healthcare expenditure, growth in population and special designation from the regulatory authority and development in the protein-based vaccines for pneumonia. Sanofi, Panacea Biotec Ltd., Pfizer Inc., Glaxo smith kline, PnuVax Incorporated, SK Bioscience, Walvax Biotechnology Co., Ltd., and Beijing Minhai Biotechnology Co., Ltd. Are the key global market players operating in pneumococcal vaccines market.

PUBLISHED: Feb, 2024 | FORMAT: PPT | LAST UPDATED: Feb, 2024 | PRICE: $3999

Pharmaceuticals

Egypt Polycystic Kidney Disease (APDKD) Market Analysis

Egypt Polycystic Kidney Disease (APDKD) Market is projected to grow from $xx Mn in 2022 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2022 - 2030. Polycystic Kidney Disease (APDKD) market is growing globally due to the he ADPKD market has experienced significant growth due to increased awareness, improved diagnostics, and advancements in treatment options. The market size is expected to expand further with the introduction of innovative therapies and the rising incidence of ADPKD. Johnson & Johnson Private Limited, Mylan N.V., Teva Pharmaceutical Industries Ltd., Sanofi, Pfizer Inc., GlaxoSmithKline plc, AbbVie Inc., Novartis AG, Taro Pharmaceutical Industries Ltd., Otsuka Pharmaceutical Co., Ltd., Eli Lilly and Company are the key global market players in polycystic kidney disease (APDKD) market.

PUBLISHED: Feb, 2024 | FORMAT: PPT | LAST UPDATED: Feb, 2024 | PRICE: $3999

Pharmaceuticals

Egypt Precision Medicine Market Analysis

Egypt Precision Medicine Market is projected to grow from $xx Mn in 2022 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2022 - 2030. Precision Medicine market is growing globally due to the advancements in genomics and molecular biology, increasing adoption of personalized therapies, rising prevalence of chronic diseases, the promise of improved patient outcomes, increasing rate of CNS Disorders such as Alzheimer's disease, epilepsy, multiple sclerosis, increasing partnerships between market players and higher technological advancements of precision medicine. Moderna, Inc., Personalis, Inc., CureVac SE, Celldex Therapeutics, BioNTech SE, Advaxis, Inc., Agenus Inc., Immatics Biotechnologies GmbH, Gritstone Oncology, ImmunityBio, Inc., bioMérieux SA, Bayer AG, Pfizer Inc., GSK plc, F. Hoffmann-La Roche Ltd. are the key market players involved in precision medicine market.

PUBLISHED: Feb, 2024 | FORMAT: PPT | LAST UPDATED: Feb, 2024 | PRICE: $3999

Pharmaceuticals

Egypt Pressure Sensor Market Analysis

Egypt Pressure Sensor Market is projected to grow from $xx Mn in 2022 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2022 - 2030. Pressure Sensor market is growing globally due to the rising demand from sectors like consumer electronics, healthcare, automotive, improvements in sensor technology, expanding use of automation, IoT applications, growing demand for pressure sensors in domestic appliances like refrigerators and washing machines. Use of pressure sensors in smartphones, increase in remote connectivity, and advancements in nanoelectromechanical system (NEMS) technology. Fuji Electric Co., Omron Corporation, Broadcom, Panasonic, Infineon Technologies AG, Honeywell International Inc., Siemens, Hitachi automotive system Ltd., Emerson Electric Co., ABB, NXP Semiconductors, STMicroelectronics, Sensata Technologies, Inc., Robert Bosch GmbH, TE Connectivity, Oxensis, Schneider Electric SE, and Baumer are the key global market players in pressure sensor market.

PUBLISHED: Feb, 2024 | FORMAT: PPT | LAST UPDATED: Feb, 2024 | PRICE: $3999

Pharmaceuticals

Egypt Progesterone Market Analysis

Egypt Progesterone Market is projected to grow from $xx Mn in 2022 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2022 - 2030. Progesterone market is growing globally due to the increasing prevalence of breast cancer which require progesterone and it’s based drugs, growth of geriatric population, growing prevalence of uterine bleeding and amenorrhea, rise in infertility treatment in women, uterine death, availability of frequently monitored formulations, technical developments in drug delivery systems, more patient awareness drive the demand for progesterone. Increased financing initiatives, the expanding trend of home healthcare and infrastructure development in the healthcare industry. Merck & Co., Inc., Pfizer Inc., Bayer AG, AbbVie Inc., Johnson & Johnson, Teva Pharmaceutical Industries Ltd., Novartis AG, Mylan N.V., Allergan plc, Amgen Inc., Lupin Pharmaceuticals, Inc., and Sun Pharmaceutical Industries Ltd. are the key global market players in progesterone market.

PUBLISHED: Feb, 2024 | FORMAT: PPT | LAST UPDATED: Feb, 2024 | PRICE: $3999

Pharmaceuticals

Egypt Proliferative Diabetic Retinopathy Market Analysis

Egypt Proliferative Diabetic Retinopathy Market is projected to grow from $xx Mn in 2022 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2022 - 2030. Proliferative Diabetic Retinopathy market is growing globally due to the increase in geriatric population, increase in the prevalence of diabetes and diabetic retinopathy, technological advancements in diagnosis and treatment of proliferative diabetic retinopathy, increasing awareness about the disease, growing healthcare expenditure, increase in research and development, government initiatives like supporting policies and reimbursement schemes. Bayer, Allergan, Novartis, Oxurion, Sirnaomics, Genentech, Alimera Sciences, Ampio Pharmaceuticals, BCN Peptides and Kowa Company Ltd. are the key global market players in Proliferative Diabetic Retinopathy Market.

PUBLISHED: Feb, 2024 | FORMAT: PPT | LAST UPDATED: Feb, 2024 | PRICE: $3999

Pharmaceuticals

Egypt Prostate Cancer Drugs Market Analysis

Egypt Prostate Cancer Drugs Market is projected to grow from $xx Mn in 2022 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2022 - 2030. Prostate Cancer Drugs market is growing globally due to the increasing incidence and prevalence of prostate cancer in men globally, aging population, technological advancements in diagnostics improvements in imaging techniques like multiparametric magnetic resonance imaging (mpMRI), prostate-specific antigen (PSA) tests, and the development of new biomarkers, growing awareness about the disease, improvements in healthcare expenditure and emergence of strong pipeline drugs. Johnson & Johnson Private Limited, Astellas Pharma Inc., Ipsen Pharma, Sanofi, Bayer AG, AbbVie Inc., AstraZeneca, Pfizer Inc., Teva Pharmaceutical Industries Ltd., Abbott, Takeda Pharmaceutical Company Limited., Bristol-Myers Squibb Company, GlaxoSmithKline plc, Novartis AG, F. Hoffmann-La Roche Ltd., Myovant Sciences GmbH, Tolmar Pharmaceuticals, Inc., Ferring B.V., Dendreon Pharmaceuticals LLC. and Genentech, Inc. are the key global market players in prostate cancer drugs market.

PUBLISHED: Feb, 2024 | FORMAT: PPT | LAST UPDATED: Feb, 2024 | PRICE: $3999

Pharmaceuticals

Egypt Psoriasis Drugs Market Analysis

Egypt Psoriasis Drugs Market is projected to grow from $xx Mn in 2022 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2022 - 2030. Psoriasis Drugs market is growing globally due to the rise in the prevalence of chronic diseases globally, growing awareness and diagnosis about the disease, advancements in biologic therapies like TNF inhibitors, IL-17 inhibitors and IL-23 inhibitors, pipeline development including small molecules and biologics, patient support programs and patient advocacy groups, increase in collaborations among pharmaceutical companies and research organizations, surge in government initiatives and development in technology. Eli Lilly & Company, Pfizer Inc., Janssen Global Services LLC, Celgene Corporation, Takeda Pharmaceutical Company Limited, Novartis International AG, Amgen Inc., Biogen Inc., Abbvie Inc., AstraZeneca, Boeringer Ingelheim International GmbH, Biogen, Johnson & Johnson Services Inc., Merck & Co. Inc., Sun Pharmaceuticals Industries Ltd., Stiefel Laboratories, UCB S.A., LEO Pharma, Cipla Inc., Rowan Bioceuticals, Glenmark Pharmaceuticals, and Win-Medicare Pvt. Ltd., are the key global market players in psoriasis drug market.

PUBLISHED: Feb, 2024 | FORMAT: PPT | LAST UPDATED: Feb, 2024 | PRICE: $3999

Pharmaceuticals

Egypt Pulmonary Arterial Hypertension Drugs Market Analysis

Egypt Pulmonary Arterial Hypertension Drugs Market is projected to grow from $xx Mn in 2022 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2022 - 2030. Pulmonary Arterial Hypertension Drugs market is growing globally due to the increasing rates of respiratory and cardiovascular diseases, as well as an ageing population. A change in lifestyle, such as excessive alcohol use, a lack of exercise, and unhealthy eating habits, has increased the risk of hypertension and high blood pressure, increasing prevalence of PAH, advancements in drug therapies, advancements in research and development, growing patient awareness leading to early diagnosis and treatment initiation, support from regulatory authorities, increasing healthcare expenditure and collaborations between pharmaceutical companies. GlaxoSmithKline PLC., Teva Pharmaceuticals Industries Ltd., Actelion Pharmaceuticals US, Inc., United Therapeutics Corp., Sandoz AG, Dr. Reddy's Laboratories Ltd, Par Pharmaceutical., Natco Pharma Ltd., Zydus Pharmaceutical USA., Hikma Pharmaceuticals PLC, Sun Pharmaceutical Industries Ltd., Mylan N.V., Sigmapharm Laboratories, LLC., Gilead Sciences, Inc., Pfizer Inc., Amneal Pharmaceutical Inc. are the key global market players in pulmonary arterial hypertension drugs market.

PUBLISHED: Feb, 2024 | FORMAT: PPT | LAST UPDATED: Feb, 2024 | PRICE: $3999

Pharmaceuticals

Egypt Rabies Vaccine Market Analysis

Egypt Rabies Vaccine Market is projected to grow from $xx Mn in 2022 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2022 - 2030. Rabies Vaccine market is growing globally due to the rising incidence of rabies, government initiatives and vaccination programs, growing pet ownership and animal healthcare realizing the importance of vaccination, technological advancements leading to more safe and effective vaccines, collaborations and partnerships between vaccine manufacturers and government bodies. Serum Institute of India Pvt. Ltd, Novartis AG, Cadila Pharmaceuticals, and Merck & Co., Inc., Sanofi, ADS Diagnostic Ltd, GSK plc, Berna Biotech Pharma GmbH, and AstraZeneca are the key global market players in rabies vaccine market.

PUBLISHED: Feb, 2024 | FORMAT: PPT | LAST UPDATED: Feb, 2024 | PRICE: $3999

Pharmaceuticals

Egypt Remicade Biosimilar Market Analysis

Egypt Remicade Biosimilar Market is projected to grow from $xx Mn in 2022 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2022 - 2030. Remicade Biosimilar market is growing globally due to the rising prevalence of autoimmune illnesses including rheumatoid arthritis, plaque psoriasis, introduction of a biosimilar version could provide financial relief for healthcare systems and increased access to essential medication for patients, quicker intravenous administration reaction times, patent expiry of branded versions will create opportunity biosimilars over other branded counterparts, thus increasing remicade biosimilar demand, growing awareness about its long-term benefits and better reimbursement scenario, technological advancements in the field of biosimilars, an increase in R&D spending by pharmaceutical companies and growing awareness about biosimilars among healthcare professionals and patients. Janssen Biotech Inc., Merck &Co., Pfizer Inc. (AC. Hospira), Celltrion Inc., Alvogen, Napp Pharmaceuticals, and Nippon Kayaku are some major players in the global Remicade (infliximab mAb) market.

PUBLISHED: Feb, 2024 | FORMAT: PPT | LAST UPDATED: Feb, 2024 | PRICE: $3999

Pharmaceuticals

Egypt Renal Cancer Drugs Market Analysis

Egypt Renal Cancer Drugs Market is projected to grow from $xx Mn in 2022 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2022 - 2030. Renal Cancer Drugs market is growing globally due to the increasing incidences of kidney diseases and renal cancer, increased demand for immunotherapies, research and development spending on new drug development, growing aging population, increasing healthcare expenditure and favorable reimbursement policies for renal cancer drugs. Pfizer Inc, AstraZeneca, Bristol-Myers Squibb Company, Dr. Reddy's Laboratories Ltd, Endo International plc, Teva Pharmaceutical Industries Ltd, Sun Pharmaceutical Industries Ltd, Mylan N.V., Novartis AG, Lupin, Cipla Inc, Aurobindo Pharma, Fresenius SE & Co. KGaA, Sanofi, Takeda Pharmaceutical Company Limited, F. Hoffmann-La Roche Ltd, Abbott are the key global market players in renal cancer drugs market.

PUBLISHED: Feb, 2024 | FORMAT: PPT | LAST UPDATED: Feb, 2024 | PRICE: $3999

Pharmaceuticals

Egypt Respiratory Drugs Market Analysis

Egypt Respiratory Drugs Market is projected to grow from $xx Mn in 2022 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2022 - 2030. Respiratory Drugs market is growing globally due to the rising elderly population, rising respiratory disease prevalence and technological developments in respiratory medications, growing demand for combination therapies due to the rising prevalence of multi-drug-resistant bacteria, and technological advancements in drug delivery devices. The chronic obstructive pulmonary disease (COPD) segment is projected to grow at the highest CAGR during the forecast period owing to the increasing prevalence of COPD across the globe. Allied Healthcare, Cardinal Health, Covidien, Drager Medical, DeVilbiss Healthcare, Fisher & Paykel Healthcare, Getinge, Hamilton Medical, Invacare Corporation, NSpire Health and ResMed are the key global market players in respiratory drugs market.

PUBLISHED: Feb, 2024 | FORMAT: PPT | LAST UPDATED: Feb, 2024 | PRICE: $3999

Pharmaceuticals

Egypt Rheumatoid Arthritis Drugs Market Analysis

Egypt Rheumatoid Arthritis Drugs Market is projected to grow from $xx Mn in 2022 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2022 - 2030. Rheumatoid Arthritis Drugs market is growing globally due to the growing aging population, increasing prevalence of rheumatoid arthritis, growing development in biologics, advancements in treatment options, increasing investment in research and development activities, increasing patient awareness and diagnosis and increased technological advancements. Pfizer Inc., Abbvie Inc., Novartis AG, Amgen Inc., Boehringer Ingelheim International GmbH., Merck & Co Inc., Sun Pharmaceutical Industries Ltd., Teva Pharmaceuticals Industries Ltd., AstraZeneca, Ampio Pharmaceuticals Inc., Lilly, Fresenius Kabi AG, Bayer AG, Casper Pharma, Dr. Reddy's Laboratories Ltd., Norbrook.

PUBLISHED: Feb, 2024 | FORMAT: PPT | LAST UPDATED: Feb, 2024 | PRICE: $3999

Pharmaceuticals

Egypt Rituximab Biosimilars Market Analysis

Egypt Rituximab Biosimilars Market is projected to grow from $xx Mn in 2022 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2022 - 2030. Rituximab biosimilars market is growing globally due to the government initiatives, increased healthcare expenditure, increase in biopharmaceutical R&D expenditure, low cost of biosimilars, aging population, increase in healthcare access, patent expiry of reference product, rising prevalence of chronic diseases and growing acceptance and confidence for biosimilars. Teva Pharmaceuticals, Novartis AG, Pfizer, BIOCAD, and Shanghai Henlius Biotech, Inc. are the key global market players in Rituximab Biosimilars Market.

PUBLISHED: Feb, 2024 | FORMAT: PPT | LAST UPDATED: Feb, 2024 | PRICE: $3999

Pharmaceuticals

Egypt Rotavirus Vaccine Market Analysis

Egypt Rotavirus Vaccine Market is projected to grow from $xx Mn in 2022 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2022 - 2030. Rotavirus Vaccine market is growing globally due to the rising burden of rotavirus infection, government immunization programs, increasing awareness and education about rotavirus infection, improved vaccine coverage, research and development activities to improve the safety and efficacy of rotavirus vaccine, international support from world health organization. Merck & Co., Inc., Bharat Biotech, GlaxoSmithKline plc., Sanofi, Lanzhou Institute of Biologicals Products Co., Ltd, BIOVIRx Inc, Serum Institute of India Pvt. Ltd., Biological E, Bio Farma, Novartis AG, Berghofer Medical Research Institute, Pfizer, Inc., CSL Limited, Emergent BioSolutions, Inc., Johnson & Johnson Services, Inc., AstraZeneca, Bavarian Nordic, Mitsubishi Tanabe Pharma Corporation., DAIICHI SANKYO COMPANY, LIMITED are the key global market players in rotavirus vaccine market.

PUBLISHED: Feb, 2024 | FORMAT: PPT | LAST UPDATED: Feb, 2024 | PRICE: $3999

Pharmaceuticals

Egypt Sarcoma Drugs Market Analysis

Egypt Sarcoma Drugs Market is projected to grow from $xx Mn in 2022 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2022 - 2030. Sarcoma Drugs market is growing globally due to the increasing incidence and prevalence of sarcoma, advances in research and development, development of targeted therapies, collaboration and partnerships between research organizations and pharmaceutical companies, patient advocacy and awareness programmes and support from regulatory authorities. Johnson & Johnson Private Limited, Abbott, AbbVie Inc., Bausch Health Companies Inc., Sun Pharmaceutical Industries Ltd., Aurobindo Pharma, Lupin, Hikma Pharmaceuticals PLC, Amneal Pharmaceuticals LLC., Pfizer Inc, Mylan N.V., Bristol-Myers Squibb Company, GSK plc., Bayer AG are the key market players in global sarcoma drugs market.

PUBLISHED: Feb, 2024 | FORMAT: PPT | LAST UPDATED: Feb, 2024 | PRICE: $3999

Pharmaceuticals

Egypt Seasonal Flu Vaccine Market Analysis

Egypt Seasonal Flu Vaccine Market is projected to grow from $xx Mn in 2022 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2022 - 2030. Seasonal Flu Vaccine market is growing globally due to the rising awareness of the necessity of getting the flu shot and the initiatives to expand immunization programmes, expanding government support and focus on seasonal flu vaccination, robust research and development activities with strong pipeline candidates, high influenza rates among children owing to demand for pediatric vaccines. GlaxoSmithKline, AstraZeneca, Seqirus, Pfizer, Novartis, Johnson & Johnson, Daiichi Sankyo Company, Bharat Biotech International Limited, Mitsubishi Tanabe Pharma Corporation are the key global market players in Seasonal flu vaccine market.

PUBLISHED: Feb, 2024 | FORMAT: PPT | LAST UPDATED: Feb, 2024 | PRICE: $3999

Pharmaceuticals

Egypt SGLT2 Inhibitor Market Analysis

Egypt SGLT2 Inhibitor Market is projected to grow from $xx Mn in 2022 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2022 - 2030. SGLT2 Inhibitor market is growing globally due to the rising prevalence of type 2 diabetes, Efficacy and Safety Profile of these drugs is good in treating type 2 diabetes, promoting weight loss and protecting from cardiovascular diseases, expanded indications of these drugs to include management of heart failure with reduced ejection fraction and chronic kidney disease, advancements in drug development. Janssen Pharmaceuticals, Eli Lilly, Bristol Myers Squibb, AstraZeneca Pharmaceuticals and Astellas are the key market players operating globally.

PUBLISHED: Feb, 2024 | FORMAT: PPT | LAST UPDATED: Feb, 2024 | PRICE: $3999

subscribe to our newsletter
up